Skip to main content

Table 1 Ovarian stimulation characteristics and outcomes of the studied groups

From: Effects of gonadotropin-releasing hormone agonist (GnRH-a) as luteal phase support in intracytoplasmic sperm injection (ICSI) cycles: a randomized controlled trial

Characteristics

Group

pvalue

GnRH agonist

Placebo

Total dose of gonadotropin (IU)

1614.25 ± 321.15

1524.25 ± 417.23

NS

Days with gonadotropin administration in current cycle

9.5 ± 1.1

9.2 ± 1.3

NS

LH (IU/ml) on day of trigger

3.24 ± 0.4

3.57 ± 0.6

NS

E2 (pg/ml) on day of trigger

2932.53 ± 92.4

2824.23 ± 101.2

NS

P (IU/ml) on day of trigger

0.84 ± 0.4

0.92 ± 0.2

NS

Endometrial thickness on day of trigger

8.5 ± 6.2

9.2 ± 5.3

NS

Endometrial pattern on day of trigger

95.3% (pattern A*)

97.7% (pattern A)

NS

Mean number of oocytes retrieved

9.5 ± 6.2

10.2 ± 5.3

NS

Mean number of embryos transferred

1.3 ± 0.5

1.6 ± 0.2

NS

Good quality embryos (A), (%)

54

49

NS

  1. E2 estradiol, LH luteinizing hormone, NS non-significant, P progesterone
  2. *Triple-line pattern consisting of a central hyperechoic line surrounded by two hypoechoic layers